Logo Light ModeLogo Dark Mode
Why Subscribe?About UsAccreditationLearning Hub CentralLive EventsBlog

Learning Hub Central

Loading…

Contact Us

info@meccinc.com
(305) 663-1628
MEC LogoMEC MedPro LogoMEC Series LogoGlobal Meetings Logo

© 2026 MyMedFlix, All Rights Reserved.

Powered By CMEGenius™
Privacy PolicyTerms and ConditionsCancellation and Refund PolicyAI Disclosure

Learning Hub Central

Filter by title, faculty, or specialty to find the course you're looking for.

SpecialtyLung(320 courses)
All specialties

Lung

320 courses

2026 Winter Cancer Symposium | Small Cell Lung Cancer Advances in LS and ED: Maintenance and Novel Targets

2026 Winter Cancer Symposium | Small Cell Lung Cancer Advances in LS and ED: Maintenance and Novel Targets

0.00 Credits
1 Chapter
Lung
Free
2026 Winter Cancer Symposium | Recent Developments from Different Targeted Pathways in NSCLC

2026 Winter Cancer Symposium | Recent Developments from Different Targeted Pathways in NSCLC

0.00 Credits
1 Chapter
Lung
Free
2026 Winter Cancer Symposium | Novel Therapeutic Approaches for NSCLC: BiTES, Bispecifics, ADC and CAR-T

2026 Winter Cancer Symposium | Novel Therapeutic Approaches for NSCLC: BiTES, Bispecifics, ADC and CAR-T

0.00 Credits
1 Chapter
Lung
Free
2026 Winter Cancer Symposium | Immunotherapy in Neoadjuvant and Adjuvant Setting: Where Are We?

2026 Winter Cancer Symposium | Immunotherapy in Neoadjuvant and Adjuvant Setting: Where Are We?

0.00 Credits
1 Chapter
Lung
Free
2026 Winter Cancer Symposium | How to Decide First Line in Non-Driver NSCLC and What is After Immunotherapy Failure?

2026 Winter Cancer Symposium | How to Decide First Line in Non-Driver NSCLC and What is After Immunotherapy Failure?

0.00 Credits
1 Chapter
Lung
Free
2026 MCM | ADC and CAR-T Cell in Non-Small Cell Lung Cancer

2026 MCM | ADC and CAR-T Cell in Non-Small Cell Lung Cancer

0.00 Credits
1 Chapter
Lung
Free
2026 MCM | Periorperative Immunotherapy in Non Small Cell Lung Cancer

2026 MCM | Periorperative Immunotherapy in Non Small Cell Lung Cancer

0.00 Credits
1 Chapter
Lung
Free
2026 MCM | Druggable Pathways in Non-Small Cell Lung Cancer: Updates

2026 MCM | Druggable Pathways in Non-Small Cell Lung Cancer: Updates

0.00 Credits
1 Chapter
Lung
Free
2026 MCM | New Developments in Stage III Unresectable Non-Small Cell Lung Cancer

2026 MCM | New Developments in Stage III Unresectable Non-Small Cell Lung Cancer

0.00 Credits
1 Chapter
Lung
Free
2026 MCM | Novel Advances in Limited and Extensive Disease Small Cell Lung Cancer

2026 MCM | Novel Advances in Limited and Extensive Disease Small Cell Lung Cancer

0.00 Credits
1 Chapter
Lung
Free
2026 Updates in Cancer Therapies | Small-Cell Lung Cancer: Updates after ASCO and ESMO 2025

2026 Updates in Cancer Therapies | Small-Cell Lung Cancer: Updates after ASCO and ESMO 2025

0.00 Credits
1 Chapter
Lung
Free
2026 Updates in Cancer Therapies | Immunotherapy in Early-Stage NSCLC: Facts and The Unknown

2026 Updates in Cancer Therapies | Immunotherapy in Early-Stage NSCLC: Facts and The Unknown

0.00 Credits
1 Chapter
Lung
Free
2026 Updates in Cancer Therapies | The Actual Landscape of Immunotherapy in Advanced Lung Cancer: First Line and Recurrence after Immunotherapy

2026 Updates in Cancer Therapies | The Actual Landscape of Immunotherapy in Advanced Lung Cancer: First Line and Recurrence after Immunotherapy

0.00 Credits
1 Chapter
Lung
Free
2026 Updates in Cancer Therapies | Updates from ASCO and ESMO 2025 in Targeted Therapy

2026 Updates in Cancer Therapies | Updates from ASCO and ESMO 2025 in Targeted Therapy

0.00 Credits
1 Chapter
Lung
Free
2025 MaTOS Lung | Session XIII | Targeted Therapy Forum-Part III Case-Based Panel Discussion

2025 MaTOS Lung | Session XIII | Targeted Therapy Forum-Part III Case-Based Panel Discussion

0.00 Credits
6 Chapters
Lung
$5,000.00
2025 MaTOS Lung | Session XII | Future Landscape on Different Genomics Drivers Biomarkers in IO and ctDNA Platforms

2025 MaTOS Lung | Session XII | Future Landscape on Different Genomics Drivers Biomarkers in IO and ctDNA Platforms

0.00 Credits
8 Chapters
Lung
$5,000.00
2025 MaTOS Lung | Session XI | Keynote Presentation: Next Generation Approaches for Tailoring Treatments for EGFR and HER-2 Mutant NSCLC

2025 MaTOS Lung | Session XI | Keynote Presentation: Next Generation Approaches for Tailoring Treatments for EGFR and HER-2 Mutant NSCLC

0.00 Credits
1 Chapter
Lung
$5,000.00
2025 MaTOS Lung | Session X | Targeted Therapy Forum-Part II Case-Based Panel Discussion

2025 MaTOS Lung | Session X | Targeted Therapy Forum-Part II Case-Based Panel Discussion

0.00 Credits
7 Chapters
Lung
$5,000.00
2025 MaTOS Lung | Session IX | Targeted Therapy Forum-Part I Case-Based Panel Discussion

2025 MaTOS Lung | Session IX | Targeted Therapy Forum-Part I Case-Based Panel Discussion

0.00 Credits
6 Chapters
Lung
$5,000.00
2025 MaTOS Lung | Session IV | Keynote Presentation

2025 MaTOS Lung | Session IV | Keynote Presentation

0.00 Credits
1 Chapter
Lung
$5,000.00
2025 MaTOS Lung | Session VII | Small Cell Lung Cancer (SCLC)

2025 MaTOS Lung | Session VII | Small Cell Lung Cancer (SCLC)

0.00 Credits
5 Chapters
Lung
$5,000.00
2025 MaTOS Lung | Session VI | Locally Advanced NSCLC-Unresectable Case-Based Panel Discussion

2025 MaTOS Lung | Session VI | Locally Advanced NSCLC-Unresectable Case-Based Panel Discussion

0.00 Credits
4 Chapters
Lung
$5,000.00
2025 MaTOS Lung | Session V | Locally Advanced NSCLC (Stage III)

2025 MaTOS Lung | Session V | Locally Advanced NSCLC (Stage III)

0.00 Credits
3 Chapters
Lung
$5,000.00
2025 MaTOS Lung | Session III | Challenging Cases | Early-Stage NSCLC Case-Based Panel Discussion

2025 MaTOS Lung | Session III | Challenging Cases | Early-Stage NSCLC Case-Based Panel Discussion

0.00 Credits
4 Chapters
Lung
$5,000.00
2025 MaTOS Lung | Session II | Early-Stage Resectable Lung Cancer

2025 MaTOS Lung | Session II | Early-Stage Resectable Lung Cancer

0.00 Credits
6 Chapters
Lung
$5,000.00
Showing 25 of 320 courses

Contact Us

info@meccinc.com
(305) 663-1628
MEC LogoMEC MedPro LogoMEC Series LogoGlobal Meetings Logo

© 2026 MyMedFlix, All Rights Reserved.

Powered By CMEGenius™
Privacy PolicyTerms and ConditionsCancellation and Refund PolicyAI Disclosure